retatrutide phase 2 nejm weight loss 48 weeks percent Early trial data for demonstrates exceptional results, reaching approximately 21% placebo-adjusted weight loss by week 48. This performance significantly exceeds all other leading obesity medications currently under Peptide Series #3 — Retatrutide
Pay in 4 interest-free payments of $7.49 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
























